Original ArticlesA two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities☆
References (0)
Cited by (0)
- ☆
Supported by grants from Genentech, Inc, and F. Hoffmann-La Roche, Ltd.
Copyright © 2001 Academic Press. All rights reserved.